These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 6418248
21. Oral versus transdermal selegiline: antidepressant-like activity in rats. Gordon MN, Muller CD, Sherman KA, Morgan DG, Azzaro AJ, Wecker L. Pharmacol Biochem Behav; 1999 Jul; 63(3):501-6. PubMed ID: 10418793 [Abstract] [Full Text] [Related]
22. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice. Boden R, Botting R, Coulson P, Spanswick G. Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496 [Abstract] [Full Text] [Related]
30. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats. Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T. Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506 [Abstract] [Full Text] [Related]
31. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Yáñez M, Fraiz N, Cano E, Orallo F. Eur J Pharmacol; 2006 Aug 07; 542(1-3):54-60. PubMed ID: 16828740 [Abstract] [Full Text] [Related]
32. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R, Salem A, Irvine RJ. Clin Exp Pharmacol Physiol; 2007 Oct 07; 34(10):1051-7. PubMed ID: 17714093 [Abstract] [Full Text] [Related]
33. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine. Green AR, Mitchell BD, Tordoff AF, Youdim MB. Br J Pharmacol; 1977 Jul 07; 60(3):343-9. PubMed ID: 890205 [No Abstract] [Full Text] [Related]
34. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat. Dyck LE, Boulton AA. Life Sci; 1992 Jul 07; 51(1):59-66. PubMed ID: 1614274 [Abstract] [Full Text] [Related]
35. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats. Tatsuta T, Kitanaka N, Kitanaka J, Morita Y, Takemura M. Neurochem Res; 2005 Nov 07; 30(11):1377-85. PubMed ID: 16341934 [Abstract] [Full Text] [Related]
36. Pharmacological studies on serotonin-mediated behaviour. Green AR. J Physiol (Paris); 1981 Nov 07; 77(2-3):437-47. PubMed ID: 6457143 [Abstract] [Full Text] [Related]
37. The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat. Assareh N, ElBatsh MM, Marsden CA, Kendall DA. Pharmacol Biochem Behav; 2012 Jan 07; 100(3):506-12. PubMed ID: 22037406 [Abstract] [Full Text] [Related]
38. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors]. Maki Y. Hokkaido Igaku Zasshi; 2001 May 07; 76(3):133-42. PubMed ID: 11481866 [Abstract] [Full Text] [Related]
39. Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior. Marek GJ, Seiden LS. Psychopharmacology (Berl); 1988 May 07; 96(2):153-60. PubMed ID: 3148140 [Abstract] [Full Text] [Related]
40. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Maki Y, Inoue T, Izumi T, Muraki I, Ito K, Kitaichi Y, Li X, Koyama T. Eur J Pharmacol; 2000 Oct 20; 406(3):411-8. PubMed ID: 11040348 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]